124 related articles for article (PubMed ID: 38547431)
1. Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia.
Tin E; Lee JB; Khatri I; Na Y; Minden MD; Zhang L
Blood Adv; 2024 Jun; 8(12):3013-3026. PubMed ID: 38547431
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms.
Lee J; Minden MD; Chen WC; Streck E; Chen B; Kang H; Arruda A; Ly D; Der SD; Kang S; Achita P; D'Souza C; Li Y; Childs RW; Dick JE; Zhang L
Clin Cancer Res; 2018 Jan; 24(2):370-382. PubMed ID: 29074605
[No Abstract] [Full Text] [Related]
3. Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.
Chen B; Lee JB; Kang H; Minden MD; Zhang L
J Exp Clin Cancer Res; 2018 Apr; 37(1):88. PubMed ID: 29690909
[TBL] [Abstract][Full Text] [Related]
4. Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer.
Lee JB; Kang H; Fang L; D'Souza C; Adeyi O; Zhang L
Clin Cancer Res; 2019 Apr; 25(7):2241-2253. PubMed ID: 30617140
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib.
Kang H; Lee JB; Khatri I; Na Y; D'Souza C; Arruda A; Minden MD; Zhang L
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680188
[TBL] [Abstract][Full Text] [Related]
6. Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells.
Fang KK; Lee J; Khatri I; Na Y; Zhang L
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37678917
[TBL] [Abstract][Full Text] [Related]
7. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
8. CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy.
Soares F; Chen B; Lee JB; Ahmed M; Ly D; Tin E; Kang H; Zeng Y; Akhtar N; Minden MD; He HH; Zhang L
Blood; 2021 Apr; 137(16):2171-2181. PubMed ID: 33270841
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
[TBL] [Abstract][Full Text] [Related]
10. Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15.
Yao J; Ly D; Dervovic D; Fang L; Lee JB; Kang H; Wang YH; Pham NA; Pan H; Tsao MS; Zhang L
J Immunother Cancer; 2019 Jan; 7(1):17. PubMed ID: 30670085
[TBL] [Abstract][Full Text] [Related]
11. CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.
Ding H; Vincelette ND; McGehee CD; Kohorst MA; Koh BD; Venkatachalam A; Meng XW; Schneider PA; Flatten KS; Peterson KL; Correia C; Lee SH; Patnaik M; Webster JA; Ghiaur G; Smith BD; Karp JE; Pratz KW; Li H; Karnitz LM; Kaufmann SH
Cancer Res; 2021 May; 81(10):2666-2678. PubMed ID: 33414171
[TBL] [Abstract][Full Text] [Related]
12. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
Bendall LJ; Kortlepel K; Gottlieb DJ
Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
[TBL] [Abstract][Full Text] [Related]
14. Light stimulates IFNgamma-mediated intercellular adhesion molecule-1 upregulation of cancer cells.
Zhang M; Guo R; Zhai Y; Fu XY; Yang D
Hum Immunol; 2003 Apr; 64(4):416-26. PubMed ID: 12651068
[TBL] [Abstract][Full Text] [Related]
15. Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.
Merims S; Li X; Joe B; Dokouhaki P; Han M; Childs RW; Wang ZY; Gupta V; Minden MD; Zhang L
Leukemia; 2011 Sep; 25(9):1415-22. PubMed ID: 21566657
[TBL] [Abstract][Full Text] [Related]
16. Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: Dominant role for TNFbeta, in concert with IFNgamma.
Eljaafari A; Van Snick J; Voisin A; Cormont F; Farre A; Bienvenu J; Bernaud J; Rigal D; Thomas X
Leukemia; 2006 Nov; 20(11):1992-2001. PubMed ID: 16990783
[TBL] [Abstract][Full Text] [Related]
17. [The role of intercellular adhesion molecule-1 in binding of acute myeloid leukemic blasts cells to human umbilical vein endothelial cells].
Zhang WH; Qiao ZH; Fan XH; Zhang XL; Li DQ
Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):413-6. PubMed ID: 12895327
[TBL] [Abstract][Full Text] [Related]
18. TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells.
Nieda M; Nicol A; Koezuka Y; Kikuchi A; Lapteva N; Tanaka Y; Tokunaga K; Suzuki K; Kayagaki N; Yagita H; Hirai H; Juji T
Blood; 2001 Apr; 97(7):2067-74. PubMed ID: 11264173
[TBL] [Abstract][Full Text] [Related]
19. The CD226-ERK1/2-LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy-resistant acute myeloid leukemia blasts and leukemia stem cells.
Wu K; Wang LM; Liu M; Xiu Y; Hu Y; Fu S; Huang H; Xu B; Xiao H
Cancer Sci; 2021 Aug; 112(8):3233-3242. PubMed ID: 34107135
[TBL] [Abstract][Full Text] [Related]
20. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia.
Zhang W; Zhang X; Fan X; Li D; Qiao Z
Clin Lab Haematol; 2006 Jun; 28(3):177-82. PubMed ID: 16706934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
